与年龄相关的甲氨酸硫氧化减少酶A可以防止膜间歇性细胞衰老和膜化
Qing Li1,2,3, Chengxiang Song1,2,4, Zisong Wei1,2,4,5
1Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, 610041, China.
GeroScience
|May 9, 2025
概括
甲氨酸硫氧化减少酶A (MSRA) 能防止动脉结石性疾病 (CAVD). 通过抑制TLR2/NF-κB通路,MSRA改善了膜化和衰老,提供了一个新的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 衰老的分子机制
- 生物化学 生化学
背景情况:
- 动脉疾病 (CAVD) 是老年人群中普遍存在的心血管疾病,与显著的发病率和死亡率有关.
- 驱动CAVD病原体的精确分子机制尚未完全理解.
- 确定关键的分子参与者对于开发有效的治疗与年龄相关的功能障碍至关重要.
研究的目的:
- 研究 metionin sulfoxide 减少酶 A (MSRA) 在 CAVD 的发展中的作用.
- 阐明MSRA影响膜化和衰老的分子途径.
- 评估MSRA作为CAVD的潜在治疗点.
主要方法:
- 鼠类大动脉叶片的RNA测序,以确定关键基因.
- 在体外研究中,使用人类膜间歇细胞 (VIC) 进行了化和衰老诱导.
- 在体内使用ApoE-/-养高胆固醇饮食的小鼠的实验.
- 分子分析包括西式涂抹,免疫光学,流细胞计和性酸酶染色.
主要成果:
- 生物信息学分析确定MSRA是膜衰老和化的关键基因.
- 沉默MSRA加剧了VIC的骨质分化和衰老,而MSRA过度表达具有保护作用.
- 在ApoE-/-小鼠中,MSRA过度表达减少了沉积和衰老标志物.
- 发现MSRA通过抑制2型受体 (TLR2) /核因子-κB (NF-κB) 途径来抑制骨质细胞分化.
结论:
- 在减轻膜化和衰老方面,MSRA起着保护作用.
- 通过抑制TLR2/NF-κB信号通路,MSRA发挥其保护作用.
- 在治疗与年龄相关的CAVD方面,MSRA是一个有前途的治疗标.
相关概念视频
Mitochondria
8.9K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
8.9K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K


